25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES Considering the high number of deaths from coronavirus disease 2019 (COVID-19) in Latin American countries, together with multiple factors that increase the prevalence of vitamin D deficiency, we aimed to determine 25-hydroxyvitamin D (25[OH]D) levels and its association with mortality in patients with critical COVID-19. SUBJECTS/METHODS This was a prospective observational study including adult patients with critical COVID-19. Data, including clinical characteristics and 25(OH)D levels measured at the time of intensive care unit admission, were collected. All patients were followed until hospital discharge or in-hospital death. The patients were divided into those surviving and deceased patient groups, and univariate and multivariate logistic regression analyses were performed to determine independent predictors of in hospital mortality. RESULTS The entire cohort comprised 94 patients with critical COVID-19 (males, 59.6%; median age, 61.5 years). The median 25(OH)D level was 12.7 ng/mL, and 15 (16%) and 79 (84%) patients had vitamin D insufficiency and vitamin D deficiency, respectively. The median serum 25(OH)D level was significantly lower in deceased patients compared with surviving (12.1 vs. 18.7 ng/mL, P < 0.001). Vitamin D deficiency was present in 100% of the deceased patients. Multivariate logistic regression analysis revealed that age, body mass index, other risk factors, and 25(OH)D level were independent predictors of mortality. CONCLUSIONS Vitamin D deficiency was present in 84% of critical COVID-19 patients. Serum 25(OH)D was independently associated with mortality in critical patients with COVID-19.
Abstract
BACKGROUND/OBJECTIVES Considering the high number of deaths from coronavirus disease 2019 (COVID-19) in Latin American countries, together with multiple factors that increase the prevalence of vitamin D deficiency, we aimed to determine 25-hydroxyvitamin D (25[OH]D) levels and its association with mortality in patients with critical COVID-19. SUBJECTS/METHODS This was a prospective observational study including adult patients with critical COVID-19. Data, including clinical characteristics and 25(OH)D levels measured at the time of intensive care unit admission, were collected. All patients were followed until hospital discharge or in-hospital death. The patients were divided into those surviving and deceased patient groups, and univariate and multivariate logistic regression analyses were performed to determine independent predictors of in hospital mortality. RESULTS The entire cohort comprised 94 patients with critical COVID-19 (males, 59.6%; median age, 61.5 years). The median 25(OH)D level was 12.7 ng/mL, and 15 (16%) and 79 (84%) patients had vitamin D insufficiency and vitamin D deficiency, respectively. The median serum 25(OH)D level was significantly lower in deceased patients compared with surviving (12.1 vs. 18.7 ng/mL, P < 0.001). Vitamin D deficiency was present in 100% of the deceased patients. Multivariate logistic regression analysis revealed that age, body mass index, other risk factors, and 25(OH)D level were independent predictors of mortality. CONCLUSIONS Vitamin D deficiency was present in 84% of critical COVID-19 patients. Serum 25(OH)D was independently associated with mortality in critical patients with COVID-19.
참고문헌 (39)
- "COVID-19" (2021)[URL]
- "Datos Abiertos Dirección General de Epidemiología" (2021)[URL]
- Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases(COVID-19)in China", Zhonghua Liu Xing Bing Xue Za Zhi, 41, pp.145~151 (2020)
- Laird E, "Vitamin D and inflammation : potential implications for severity of COVID-19", Ir Med J, 113, pp.81~ (2020)
- Palacios C, "Is vitamin D deficiency a major global public health problem?", J Steroid Biochem Mol Biol., 144(Pt A), pp.138~145 (2014)
- Contreras-Manzano A, "Vitamin D status by sociodemographic factors and body mass index in Mexican women at reproductive age", Salud Publica Mex, 59, pp.518~525 (2017)
- "Concentraciones séricas de vitamina D en niños, adolescentes y adultos mexicanos" (2011)[URL]
- Greiller CL, "Modulation of the immune response to respiratory viruses by vitamin D", Nutrients, 7, pp.4240~4270 (2015)
- Sørensen OE, "Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3", Blood, 97, pp.3951~3959 (2001)
- Barlow PG, "Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37", PLoS One, 6, pp.e25333~ (2011)
- Karahan S, "Impact of serum 25(OH)vitamin D level on mortality in patients with COVID-19 in Turkey", J Nutr Health Aging, 25, pp.189~196 (2021)
- De Smet D, "Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality", Am J Clin Pathol, 155, pp.381~388 (2021)
- Alguwaihes AM, "Diabetes and COVID-19 among hospitalized patients in Saudi Arabia : a single-centre retrospective study", Cardiovasc Diabetol, 19, pp.205~ (2020)
- Amrein K, "Vitamin D deficiency 2.0: an update on the current status worldwide", Eur J Clin Nutr, 74, pp.1498~1513 (2020)
- Sassi F, "Vitamin D : Nutrient, Hormone, and Immunomodulator", Nutrients, 10, pp.1656~ (2018)
- Hewison M, "Antibacterial effects of vitamin D", Nat Rev Endocrinol, 7, pp.337~345 (2011)
- Hansdottir S, "Respiratory epithelial cells convert inactive vitamin D to its active form : potential effects on host defense", J Immunol, 181, pp.7090~7099 (2008)
- Vanherwegen AS, "Regulation of immune function by vitamin D and its use in diseases of immunity", Endocrinol Metab Clin North Am, 46, pp.1061~1094 (2017)
- Hewison M, "Vitamin D and the immune system : new perspectives on an old theme", Endocrinol Metab Clin North Am, 39, pp.365~379 (2010)
- Grant WB, "Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths", Nutrients, 12, pp.988~ (2020)
- Brito A, "Less than adequate vitamin D status and intake in Latin America and the Caribbean : a problem of unknown magnitude", Food Nutr Bull, 34, pp.52~64 (2013)
- Carrillo-Vega MF, "Vitamin D deficiency in older adults and its associated factors : a cross-sectional analysis of the Mexican Health and Aging Study", Arch Osteoporos, 12, pp.8~ (2017)
- Mendes MM, "Vitamin D status in the tropics : is sunlight exposure the main determinant?", Nutr Bull, 43, pp.428~434 (2018)
- Norval M, "Does chronic sunscreen use reduce vitamin D production to insufficient levels?", Br J Dermatol, 161, pp.732~736 (2009)
- Brenner M, "The protective role of melanin against UV damage in human skin", Photochem Photobiol, 84, pp.539~549 (2008)
- Vranić L, "Vitamin D deficiency : consequence or cause of obesity?", Medicina(Kaunas), 55, pp.541~ (2019)
- Chang SW, "Vitamin D and health-The missing vitamin in humans", Pediatr Neonatol, 60, pp.237~244 (2019)
- López-Feldman A, "Air pollution exposure and COVID-19 : a look at mortality in Mexico City using individual-level data", Sci Total Environ, 756, pp.143929~ (2021)
- Wang H, "Vitamin D and chronic diseases", Aging Dis, 8, pp.346~353 (2017)
- Docherty AB, "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", BMJ, 369, pp.m1985~ (2020)
- Rezende LF, "Adults at high-risk of severe coronavirus disease-2019(Covid-19)in Brazil", Rev Saude Publica, 54, pp.50~ (2020)
- Martínez-Zavala N, "Vitamin D deficiency in Mexicans have a high prevalence : a cross-sectional analysis of the patients from the Centro Médico Nacional 20 de Noviembre", Arch Osteoporos, 15, pp.88~ (2020)
- Acharya R, "Low serum albumin predicts severe outcomes in COVID-19 infection : a single-center retrospective case-control study", J Clin Med Res, 13, pp.258~267 (2021)
- Munshi R, "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients", J Med Virol, 93, pp.733~740 (2021)
- Vassiliou AG, "Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk : a pilot study on a Greek ICU cohort", Nutrients, 12, pp.3773~ (2020)
- Allegra A, "Vitamin deficiency as risk factor for SARS-CoV-2 infection : correlation with susceptibility and prognosis", Eur Rev Med Pharmacol Sci, 24, pp.9721~9738 (2020)
- Cano F, "Renin angiotensin axis, angiotensin converting enzyme 2 and coronavirus", Rev Chil Pediatr, 91, pp.330~338 (2020)
- Catanzaro M, "Immune response in COVID-19 : addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2", Signal Transduct Target Ther, 5, pp.84~ (2020)
- Martineau AR, "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data", BMJ, 356, pp.i6583~ (2017)